Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 01:30:00 25/09/2026 am IST			5-day change	1st Jan Change
11.72 ^USD	-1.43%		-6.98%	-25.26%

08/09	Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon	MT
08/09	Monte Rosa Therapeutics Initiates Phase 2 Clinical Study for Vav1-Directed Molecular Glue Degrader MRT-6160	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
MONTE ROSA THERAPEUTICS, INC.	100Cr	-	BB	-	-
LONZA GROUP AG	4.8TCr		AAA
IQVIA HOLDINGS INC.	4.53TCr		AAA
BEONE MEDICINES AG	4.09TCr		-
REVOLUTION MEDICINES, INC.	4.28TCr	-	B	-	-
CELLTRION, INC.	2.96TCr		A
MEDPACE HOLDINGS, INC.	1.73TCr		BBB
EUROFINS SCIENTIFIC SE	1.53TCr		AA
ASCENDIS PHARMA A/S	1.52TCr	-	-	-	-
TEMPUS AI, INC.	1.48TCr		A		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.41TCr		AA
ICON PUBLIC LIMITED COMPANY	1.34TCr		AAA
GENSCRIPT BIOTECH CORPORATION	1.16TCr		AA		-
BIO-TECHNE CORPORATION	1.14TCr		AA
PHARMARON BEIJING CO., LTD.	1.1TCr		AA
KYMERA THERAPEUTICS, INC.	962.97Cr	-	BBB	-	-
QIAGEN N.V.	921.5Cr		AAA
PROTAGONIST THERAPEUTICS, INC.	888.7Cr		BB		-
ABIVAX	807.25Cr	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	786.76Cr	-	B	-	-
Average	1.88TCr		A
Weighted average by Cap.			A